AI-generated summary
The authors conducted a systematic review of photodynamic therapy combined with photobiomodulation for recurrent herpes labialis, searching PubMed and Cochrane. No clinical trials were found, so only case reports were included, and all used methylene blue with a 660 nm light source. The authors report that all case reports showed good results for symptoms, healing and recurrence without side effects, but they conclude that controlled double-blind placebo studies are needed to establish an effective protocol.
- Who or what was studied
- Individuals with recurrent herpes labialis treated in included case reports
- Wavelengths
- 660 nm
- Limits stated in the abstract
- Only case reports were included because no clinical trials were found, and the authors state that double-blind placebo studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Systematic review, Laser, Power output, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.